IL97629A0 - Bcrf1 antagonists for treating epstein-barr virus infections - Google Patents

Bcrf1 antagonists for treating epstein-barr virus infections

Info

Publication number
IL97629A0
IL97629A0 IL97629A IL9762991A IL97629A0 IL 97629 A0 IL97629 A0 IL 97629A0 IL 97629 A IL97629 A IL 97629A IL 9762991 A IL9762991 A IL 9762991A IL 97629 A0 IL97629 A0 IL 97629A0
Authority
IL
Israel
Prior art keywords
bcrf1
antagonists
barr virus
virus infections
treating
Prior art date
Application number
IL97629A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL97629A0 publication Critical patent/IL97629A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL97629A 1990-03-26 1991-03-21 Bcrf1 antagonists for treating epstein-barr virus infections IL97629A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49898590A 1990-03-26 1990-03-26

Publications (1)

Publication Number Publication Date
IL97629A0 true IL97629A0 (en) 1992-06-21

Family

ID=23983319

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97629A IL97629A0 (en) 1990-03-26 1991-03-21 Bcrf1 antagonists for treating epstein-barr virus infections

Country Status (23)

Country Link
US (1) US5756342A (xx)
EP (1) EP0522010B1 (xx)
JP (1) JP2509774B2 (xx)
KR (1) KR960004856B1 (xx)
CN (1) CN1056245A (xx)
AT (1) ATE126704T1 (xx)
AU (1) AU650013B2 (xx)
CA (1) CA2079230C (xx)
DE (1) DE69112392T2 (xx)
DK (1) DK0522010T3 (xx)
ES (1) ES2076526T3 (xx)
FI (1) FI924278A (xx)
GR (1) GR3017920T3 (xx)
HU (1) HUT63339A (xx)
IE (1) IE70910B1 (xx)
IL (1) IL97629A0 (xx)
MX (1) MX9203522A (xx)
MY (1) MY106163A (xx)
NO (1) NO923749D0 (xx)
OA (1) OA09674A (xx)
PT (1) PT97108B (xx)
WO (1) WO1991014451A1 (xx)
ZA (1) ZA912138B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6887096A (en) * 1996-09-11 1998-04-02 Patrick T. Prendergast Immune direction therapy
CN111574621B (zh) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种中和eb病毒的单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614810A (en) * 1984-09-24 1986-09-30 Pennwalt Corporation 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)

Also Published As

Publication number Publication date
FI924278A0 (fi) 1992-09-24
AU7588291A (en) 1991-10-21
CN1056245A (zh) 1991-11-20
JP2509774B2 (ja) 1996-06-26
DE69112392D1 (de) 1995-09-28
IE70910B1 (en) 1997-01-15
FI924278A (fi) 1992-09-24
DK0522010T3 (da) 1996-01-15
JPH05501116A (ja) 1993-03-04
DE69112392T2 (de) 1996-02-01
EP0522010B1 (en) 1995-08-23
MX9203522A (es) 1992-07-01
CA2079230A1 (en) 1991-09-27
NO923749L (no) 1992-09-25
IE910942A1 (en) 1991-10-09
EP0522010A1 (en) 1993-01-13
NO923749D0 (no) 1992-09-25
PT97108B (pt) 1998-10-30
KR960004856B1 (ko) 1996-04-16
GR3017920T3 (en) 1996-01-31
HUT63339A (en) 1993-08-30
OA09674A (en) 1993-05-15
ATE126704T1 (de) 1995-09-15
WO1991014451A1 (en) 1991-10-03
CA2079230C (en) 2001-02-13
ZA912138B (en) 1991-12-24
ES2076526T3 (es) 1995-11-01
US5756342A (en) 1998-05-26
AU650013B2 (en) 1994-06-09
PT97108A (pt) 1991-11-29
MY106163A (en) 1995-03-31

Similar Documents

Publication Publication Date Title
MY107079A (en) Method of reducing immunoglobulin e responses
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
MY107386A (en) Method of preventing or reducing eosinophilia
WO1991007986A8 (en) Method of treating septic shock
OA09674A (en) Bcrf1 antagonists for treating epstein-barr virus infections
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.